Back to Selection     Print       Date : 30 Nov 2025
Fund Summary
Bandhan Focused Fund Reg (G)
[Equity: Focused]  
 
Fund Details
Fund Type Growth Launch Date 16-Mar-06
Corpus(Cr.) 2086.0 Latest NAV 84.894 As on 29-01-2026
Equity(%) 99.46 52 Week High 91.193
Debt(%) 0.54 52 Week Low 75.133
Others(%) 0.0 Exit Load For units in excess of 10% of the investment, 1% will be charged for redemption within 365 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 2.05
Scheme Benchmark BSE 500 TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Kirthi Jain
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme aims to generate capital appreciation by investing in a concentrated portfolio of equity & equity related instruments of upto 30 stocks.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 32.12%
Top 10 Holdings 52.56%
Top 25 Holdings 93.37%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Banking & Financial 22.52
Pharma & Biotech 14.69
Finance & Investments 11.27
Retail 9.26
Agricultural & Farm Machinery 7.35
Food Beverage & Tobacco 6.4
Software & Services 5.98
Technology 3.86
Construction 3.72
Chemicals 2.8
FMCG 2.77
Petroleum Products 2.68
Telecom 2.31
Energy 1.94
Textiles 1.91
Cash 0.54
 
 
 
 
 
Portfolio Metrics
PB Ratio 2.76
PE Ratio 18.09
 
Top 25 Holdings
Holdings Net Asset(%)
POWER FINANCE CORPORATION LTD. 7.54
LT Foods Limited 7.35
HDFC Bank Limited 6.28
State Bank of India 6.23
ICICI Bank Limited 4.72
Jubilant Pharmova Limited 4.46
Prestige Estates Projects Limited 4.21
Glenmark Pharmaceuticals Limited 4.12
One 97 Communications Limited 3.86
TILAKNAGAR INDUSTRIES LIMITED 3.79
CHOLAMANDALAM FIN HOL LTD 3.73
Larsen & Toubro Limited 3.72
SOUTH INDIAN BANK LTD 3.55
Infosys Limited 3.29
Deepak Fertilisers & Petrochemicals Corp. Ltd. 2.80
ITC Limited 2.77
SIGNATURE GLOBAL (INDIA) LIMITED 2.74
Reliance Industries Limited 2.68
Varun Beverages Limited 2.61
Aurobindo Pharma Limited 2.37
Eternal Limited 2.31
Bharti Airtel Limited 2.31
Tata Consultancy Services Limited 2.05
NTPC Limited 1.94
Mankind Pharma Limited 1.94

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-2.25% -6.91% -3.79% 3.32%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
-1.95% -2.33% 2.82% 11.06%
 
Scheme Benchmark [NSE - Nifty 500 TRI]
-2.21% -3.32% 0.92% 9.97%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
10.50% 19.12% 14.10% 13.42%
 
 
9.44% 14.31% 14.62% 14.28%
 
 
9.38% 16.92% 16.58% 15.08%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Bandhan Focused Fund Reg (G) 14.03% 0.7990 11.2610% 42.9530 0.1184
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Bandhan Focused Fund Reg (G) 5.1338% 0.0004 0.1361 8.7342 0.6880
 
Back to Selection